Biological Research For Nursing

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Register here to gain access to SAGE's 500+ Journals Online

Click here for more information on The Virtual Advisor

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Merkle, C. J.
Right arrow Articles by Montgomery, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Merkle, C. J.
Right arrow Articles by Montgomery, D. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Biological Research For Nursing, Vol. 2, No. 1, 5-14 (2000)
DOI: 10.1177/109980040000200102

Methotrexate Causes Apoptosis in Postmitotic Endothelial Cells

Carrie J. Merkle, PhD, RN

College of Nursing and the Department of Physiology, The University of Arizona, Tucson, AZ 85721.cmerkle{at}nursing.arizona.edu

Ida M. (Ki) Moore, DNS, RN, FAAN

Beau S. Penton

Bonny J. Torres, BSN, RN

College of Nursing, The University of Arizona, Tucson, AZ 85721.

Renee K. Cueny, BS

Research Service, Southern Arizona VA Health Care System, Tucson, AZ 85723.

Richard C. Schaeffer, Jr., PhD

Department of Physiology

David W. Montgomery, PhD

Department of Surgery, College of Medicine, The University of Arizona, Tucson, AZ 85721.

Methotrexate (MTX) is a commonly used chemotherapy agent for a variety of cancers. However, therapeutic levels are associated with numerous untoward effects such as central nervous system damage in children with acute lymphoblastic leukemia. The purpose of this study was to determine if MTX caused injury to endothelial cells using cultured bovine pulmonary artery endothelial cells as a model. Light microscopy showed gaps between cells and reduced numbers of endothelial cells after exposure to MTX (10 M), a range consistent with therapeutic drug levels. Proliferation and viability of subconfluent and confluent MTX-treated endothelial cells were measured by colorimetric (MTS) assay. There was a significant decline in cell numbers in MTX-treated subconfluent (growing) cells cultured after 4 days of MTX exposure compared to controls, as expected. However, there was also an unexpected decline in cell numbers in MTX-treated postmitotic endothelial cells after 1, 3, and 4 days of drug exposure. This suggested that MTX induced endothelial cell death. Fluorescent ApoAlertTMEnhanced Annexin-V binding demonstrated apoptosis in endothelial cells after 1 day of MTX exposure. Apoptosis was confirmed by a DNA fragment assay. This is apparently the first report of MTX-induced apoptosis of postmitotic, cultured endothelial cells. The findings suggest that apoptosis may be one mechanism of MTX-induced injury to endothelial cells.

Key Words: Methotrexate • apoptosis • endothelial • cells • cell proliferation • cell viability • DNA fragmentation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Biol Res NursHome page
I. M. Moore, C. J. Merkle, P. Miketova, R. K. Salyer, B. J. Torres, R. C. Schaeffer Jr, and D. W. Montgomery
Cytosine arabinoside induces programmed endothelial cell death through the caspase-3 pathway.
Biol Res Nurs, April 1, 2006; 7(4): 289 - 296.
[Abstract] [PDF]


Home page
Biol Res NursHome page
P. Miketova, K. Kaemingk, M. Hockenberry, A. Pasvogel, J. Hutter, K. Krull, and I. M. Moore
Oxidative Changes in Cerebral Spinal Fluid Phosphatidylcholine during Treatment for Acute Lymphoblastic Leukemia
Biol Res Nurs, January 1, 2005; 6(3): 187 - 195.
[Abstract] [PDF]